New ultrasound techniques promise further advances in AKI and CKD

Travis D. Hull, Anupam Agarwal, Kenneth Hoyt

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

AKI and CKD are important clinical problems because they affectmany patients and the associated diagnostic and treatment paradigms are imperfect. Ultrasound is a cost-effective, noninvasive, and simple imaging modality that offers a multitude of means to improve the diagnosis, monitoring, and treatment of both AKI and CKD, especially considering recent advances in this technique. Ultrasound alone can attenuate AKI and prevent CKD by stimulating the splenic cholinergic anti-inflammatory pathway. Additionally,microbubble contrast agents are improving the sensitivity and specificity of ultrasound for diagnosing kidney disease, especially when these agents are conjugated to ligand-specific mAbs or peptides, which make the dynamic assessment of disease progression and response to treatment possible.More recently, drug-loadedmicrobubbles have been developed and the load release by ultrasound exposure has been shown to be a highly specific treatment modality, making the potential applications of ultrasound even more promising. This review focuses on the multiple strategies for using ultrasound with and without microbubble technology for enhancing our understanding of the pathophysiology of AKI and CKD.

Original languageEnglish (US)
Pages (from-to)3452-3460
Number of pages9
JournalJournal of the American Society of Nephrology
Volume28
Issue number12
DOIs
StatePublished - Dec 1 2017

    Fingerprint

ASJC Scopus subject areas

  • Nephrology

Cite this